Trxade Group Inc (OTCMKTS:TRXD – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.68 and traded as low as $0.32. Trxade Group shares last traded at $0.36, with a volume of 140,804 shares changing hands.
Trxade Group Stock Performance
The business has a 50-day moving average price of $0.39 and a two-hundred day moving average price of $0.68. The stock has a market capitalization of $14.12 million, a P/E ratio of -36.00 and a beta of 1.35. The company has a current ratio of 4.51, a quick ratio of 4.45 and a debt-to-equity ratio of 0.26.
Trxade Group Company Profile
Trxade Group, Inc owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The company offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com and InventoryRx.com, which are Web-based pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service-based desktop software application, which provides daily drug pricing and analytics to the independent pharmacists.
Recommended Stories
- Get a free copy of the StockNews.com research report on Trxade Group (TRXD)
- Meta Platforms: Efficiency Gains Momentum, Stock Accelerates
- Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
- SentinelOne: Reversal In-Play For Cybersecurity Stocks
- Is Sportradar Group A Growth Stock To Bet On In 2023?
- Strong Guidance says Boeing is Ready for Takeoff
Receive News & Ratings for Trxade Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trxade Group and related companies with MarketBeat.com's FREE daily email newsletter.